Global Biologics Drug Discovery Market 2019 by Manufacturers, Countries, Type and Application, Forecast to 2024

Table of Contents

1 Biologics Drug Discovery Market Overview

• 1.1 Product Overview and Scope of Biologics Drug Discovery
• 1.2 Classification of Biologics Drug Discovery by Types
  • 1.2.1 Global Biologics Drug Discovery Revenue Comparison by Types (2019-2024)
  • 1.2.2 Global Biologics Drug Discovery Revenue Market Share by Types in 2018
  • 1.2.3 Biologicals
  • 1.2.4 Monoclonal Antibodies
  • 1.2.5 Recombinant Proteins
  • 1.2.6 Other Biologics
• 1.3 Global Biologics Drug Discovery Market by Application
  • 1.3.1 Global Biologics Drug Discovery Market Size and Market Share Comparison by Applications (2014-2024)
  • 1.3.2 Hospitals
  • 1.3.3 Clinics
  • 1.3.4 Research Labs
  • 1.3.5 Diagnostic Centers
  • 1.3.6 Others
• 1.4 Global Biologics Drug Discovery Market by Regions
  • 1.4.1 Global Biologics Drug Discovery Market Size (Million USD) Comparison by Regions (2014-2024)
  • 1.4.1 North America (USA, Canada and Mexico) Biologics Drug Discovery Status and Prospect (2014-2024)
  • 1.4.2 Europe (Germany, France, UK, Russia and Italy) Biologics Drug Discovery Status and Prospect (2014-2024)
  • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Biologics Drug Discovery Status and Prospect (2014-2024)
  • 1.4.4 South America (Brazil, Argentina, Colombia) Biologics Drug Discovery Status and Prospect (2014-2024)
  • 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Biologics Drug Discovery Status and Prospect (2014-2024)
• 1.5 Global Market Size of Biologics Drug Discovery (2014-2024)

2 Manufacturers Profiles

• 2.1 GenScript
  • 2.1.1 Business Overview
  • 2.1.2 Biologics Drug Discovery Type and Applications
    • 2.1.2.1 Product A
    • 2.1.2.2 Product B
  • 2.1.3 GenScript Biologics Drug Discovery Revenue, Gross Margin and Market Share (2017-2018)
• 2.2 Roche
  • 2.2.1 Business Overview
  • 2.2.2 Biologics Drug Discovery Type and Applications
    • 2.2.2.1 Product A
    • 2.2.2.2 Product B
  • 2.2.3 Roche Biologics Drug Discovery Revenue, Gross Margin and Market Share (2017-2018)
• 2.3 Pfizer
  • 2.3.1 Business Overview
  • 2.3.2 Biologics Drug Discovery Type and Applications
    • 2.3.2.1 Product A
    • 2.3.2.2 Product B
  • 2.3.3 Pfizer Biologics Drug Discovery Revenue, Gross Margin and Market Share (2017-2018)
• 2.4 Novartis
  • 2.4.1 Business Overview
  • 2.4.2 Biologics Drug Discovery Type and Applications
    • 2.4.2.1 Product A
    • 2.4.2.2 Product B
  • 2.4.3 Novartis Biologics Drug Discovery Revenue, Gross Margin and Market Share (2017-2018)
• 2.5 Sanofi
  • 2.5.1 Business Overview
  • 2.5.2 Biologics Drug Discovery Type and Applications
    • 2.5.2.1 Product A
    • 2.5.2.2 Product B
  • 2.5.3 Sanofi Biologics Drug Discovery Revenue, Gross Margin and Market Share (2017-2018)
• 2.6 Merck
  • 2.6.1 Business Overview
  • 2.6.2 Biologics Drug Discovery Type and Applications
    • 2.6.2.1 Product A
    • 2.6.2.2 Product B
  • 2.6.3 Merck Biologics Drug Discovery Revenue, Gross Margin and Market Share (2017-2018)
• 2.7 GlaxoSmithKline
  • 2.7.1 Business Overview
  • 2.7.2 Biologics Drug Discovery Type and Applications
    • 2.7.2.1 Product A
    • 2.7.2.2 Product B
  • 2.7.3 GlaxoSmithKline Biologics Drug Discovery Revenue, Gross Margin and Market Share (2017-2018)
• 2.8 AstraZeneca
  • 2.8.1 Business Overview
  • 2.8.2 Biologics Drug Discovery Type and Applications
    • 2.8.2.1 Product A
    • 2.8.2.2 Product B
  • 2.8.3 AstraZeneca Biologics Drug Discovery Revenue, Gross Margin and Market Share (2017-2018)
• 2.9 AbbVie
  • 2.9.1 Business Overview
  • 2.9.2 Biologics Drug Discovery Type and Applications
    • 2.9.2.1 Product A
    • 2.9.2.2 Product B
  • 2.9.3 AbbVie Biologics Drug Discovery Revenue, Gross Margin and Market Share (2017-2018)
• 2.10 Amgen
  • 2.10.1 Business Overview
  • 2.10.2 Biologics Drug Discovery Type and Applications
    • 2.10.2.1 Product A
    • 2.10.2.2 Product B
  • 2.10.3 Amgen Biologics Drug Discovery Revenue, Gross Margin and Market Share (2017-2018)
• 2.11 Bristol-Myers Squibb
  • 2.11.1 Business Overview
  • 2.11.2 Biologics Drug Discovery Type and Applications
    • 2.11.2.1 Product A
    • 2.11.2.2 Product B
  • 2.11.3 Bristol-Myers Squibb Biologics Drug Discovery Revenue, Gross Margin and Market Share (2017-2018)
• 2.12 Novo Nordisk
  • 2.12.1 Business Overview
  • 2.12.2 Biologics Drug Discovery Type and Applications
    • 2.12.2.1 Product A
    • 2.12.2.2 Product B
  • 2.12.3 Novo Nordisk Biologics Drug Discovery Revenue, Gross Margin and Market Share (2017-2018)
• 2.13 Allergan
  • 2.13.1 Business Overview
  • 2.13.2 Biologics Drug Discovery Type and Applications
    • 2.13.2.1 Product A
    • 2.13.2.2 Product B
  • 2.13.3 Allergan Biologics Drug Discovery Revenue, Gross Margin and Market Share (2017-2018)
• 2.14 Astellas Pharma
  • 2.14.1 Business Overview
  • 2.14.2 Biologics Drug Discovery Type and Applications
    • 2.14.2.1 Product A
    • 2.14.2.2 Product B
  • 2.14.3 Astellas Pharma Biologics Drug Discovery Revenue, Gross Margin and Market Share (2017-2018)
• 2.15 Teva Pharmaceutical Industries
  • 2.15.1 Business Overview
  • 2.15.2 Biologics Drug Discovery Type and Applications
    • 2.15.2.1 Product A
    • 2.15.2.2 Product B
  • 2.15.3 Teva Pharmaceutical Industries Biologics Drug Discovery Revenue, Gross Margin and Market Share (2017-2018)

3 Global Biologics Drug Discovery Market Competition, by Players

• 3.1 Global Biologics Drug Discovery Revenue and Share by Players (2014-2019)
• 3.2 Market Concentration Rate
  • 3.2.1 Top 5 Biologics Drug Discovery Players Market Share
  • 3.2.2 Top 10 Biologics Drug Discovery Players Market Share
• 3.3 Market Competition Trend

4 Global Biologics Drug Discovery Market Size by Regions

• 4.1 Global Biologics Drug Discovery Revenue and Market Share by Regions
• 4.2 North America Biologics Drug Discovery Revenue and Growth Rate (2014-2019)
• 4.3 Europe Biologics Drug Discovery Revenue and Growth Rate (2014-2019)
• 4.4 Asia-Pacific Biologics Drug Discovery Revenue and Growth Rate (2014-2019)
• 4.5 South America Biologics Drug Discovery Revenue and Growth Rate (2014-2019)
• 4.6 Middle East and Africa Biologics Drug Discovery Revenue and Growth Rate (2014-2019)

5 North America Biologics Drug Discovery Revenue by Countries

• 5.1 North America Biologics Drug Discovery Revenue by Countries (2014-2019)
• 5.2 USA Biologics Drug Discovery Revenue and Growth Rate (2014-2019)
• 5.3 Canada Biologics Drug Discovery Revenue and Growth Rate (2014-2019)
• 5.4 Mexico Biologics Drug Discovery Revenue and Growth Rate (2014-2019)

6 Europe Biologics Drug Discovery Revenue by Countries

• 6.1 Europe Biologics Drug Discovery Revenue by Countries (2014-2019)
• 6.2 Germany Biologics Drug Discovery Revenue and Growth Rate (2014-2019)
• 6.3 UK Biologics Drug Discovery Revenue and Growth Rate (2014-2019)
• 6.4 France Biologics Drug Discovery Revenue and Growth Rate (2014-2019)
• 6.5 Russia Biologics Drug Discovery Revenue and Growth Rate (2014-2019)
• 6.6 Italy Biologics Drug Discovery Revenue and Growth Rate (2014-2019)

7 Asia-Pacific Biologics Drug Discovery Revenue by Countries

• 7.1 Asia-Pacific Biologics Drug Discovery Revenue by Countries (2014-2019)
• 7.2 China Biologics Drug Discovery Revenue and Growth Rate (2014-2019)
• 7.3 Japan Biologics Drug Discovery Revenue and Growth Rate (2014-2019)
• 7.4 Korea Biologics Drug Discovery Revenue and Growth Rate (2014-2019)
• 7.5 India Biologics Drug Discovery Revenue and Growth Rate (2014-2019)
• 7.6 Southeast Asia Biologics Drug Discovery Revenue and Growth Rate (2014-2019)

8 South America Biologics Drug Discovery Revenue by Countries

• 8.1 South America Biologics Drug Discovery Revenue by Countries (2014-2019)
• 8.2 Brazil Biologics Drug Discovery Revenue and Growth Rate (2014-2019)
• 8.3 Argentina Biologics Drug Discovery Revenue and Growth Rate (2014-2019)
• 8.4 Colombia Biologics Drug Discovery Revenue and Growth Rate (2014-2019)

9 Middle East and Africa Revenue Biologics Drug Discovery by Countries

• 9.1 Middle East and Africa Biologics Drug Discovery Revenue by Countries (2014-2019)
• 9.2 Saudi Arabia Biologics Drug Discovery Revenue and Growth Rate (2014-2019)
• 9.3 UAE Biologics Drug Discovery Revenue and Growth Rate (2014-2019)
• 9.4 Egypt Biologics Drug Discovery Revenue and Growth Rate (2014-2019)
• 9.5 Nigeria Biologics Drug Discovery Revenue and Growth Rate (2014-2019)
• 9.6 South Africa Biologics Drug Discovery Revenue and Growth Rate (2014-2019)

10 Global Biologics Drug Discovery Market Segment by Type

• 10.1 Global Biologics Drug Discovery Revenue and Market Share by Type (2014-2019)
• 10.2 Global Biologics Drug Discovery Market Forecast by Type (2019-2024)
• 10.3 Biologicals Revenue Growth Rate (2014-2024)
• 10.4 Monoclonal Antibodies Revenue Growth Rate (2014-2024)
• 10.5 Recombinant Proteins Revenue Growth Rate (2014-2024)
• 10.6 Other Biologics Revenue Growth Rate (2014-2024)

11 Global Biologics Drug Discovery Market Segment by Application

• 11.1 Global Biologics Drug Discovery Revenue Market Share by Application (2014-2019)
• 11.2 Biologics Drug Discovery Market Forecast by Application (2019-2024)
• 11.3 Hospitals Revenue Growth (2014-2019)
• 11.4 Clinics Revenue Growth (2014-2019)
• 11.5 Research Labs Revenue Growth (2014-2019)
• 11.6 Diagnostic Centers Revenue Growth (2014-2019)
• 11.7 Others Revenue Growth (2014-2019)

12 Global Biologics Drug Discovery Market Size Forecast (2019-2024)

• 12.1 Global Biologics Drug Discovery Market Size Forecast (2019-2024)
• 12.2 Global Biologics Drug Discovery Market Forecast by Regions (2019-2024)
• 12.3 North America Biologics Drug Discovery Revenue Market Forecast (2019-2024)
• 12.4 Europe Biologics Drug Discovery Revenue Market Forecast (2019-2024)
• 12.5 Asia-Pacific Biologics Drug Discovery Revenue Market Forecast (2019-2024)
• 12.6 South America Biologics Drug Discovery Revenue Market Forecast (2019-2024)
• 12.7 Middle East and Africa Biologics Drug Discovery Revenue Market Forecast (2019-2024)

13 Research Findings and Conclusion

14 Appendix

• 14.1 Methodology